Ingersoll Rand (IR): Aftermarket Strength Supports a Hold
Ingersoll Rand posted solid Q2 growth, margin expansion in Precision and Science Technologies, and raised 2026 guidance. The stock looks high quality, but valuation and leverage keep the stance at Hold.
Ingersoll Rand (IR) looks like a solid industrial compounder, earning an overall grade of B and a Hold rating. Our fair value is $82, which reflects healthy 2026 growth guidance, strong free cash flow conversion, and a business mix supported by a 36% aftermarket contribution, but also a valuation that already prices in much of the good news.
Thesis
Ingersoll Rand Inc. (IR) is a high-quality industrial compounder with two valuable engines: mission-critical equipment and a growing aftermarket base. The investment case rests on 2026 revenue guidance of 4.5% to 6.5%, adjusted EPS guidance of $3.45 to $3.57, free cash flow conversion of approximately 95%, and Q2 organic revenue growth of 4%.
The Q2 2026 report showed $2.05B of revenue, adjusted EPS of $0.86, $269M of free cash flow, and orders of just over $2.0B. Precision and Science Technologies produced 31.5% adjusted EBITDA margins, while Industrial Technologies and Services benefited from positive organic revenue growth in every region. Management also raised revenue guidance and said adjusted EPS should finish near the high end of its range.
The main restraint is valuation and leverage. IR trades at 31.1x trailing earnings and 18.9x forward earnings, carries $4.85B of debt against $1.25B of cash, and reported 2025 net income of $581M, down from $839M in 2024. At the quoted $78.57 reference price, the risk-reward is balanced rather than one-sided. The appropriate stance for a moderate-risk, medium-term investor is Hold, with the strongest buying opportunity reserved for a meaningful pullback.
Company Overview
Ingersoll Rand is a global industrial technology company founded in 1859 and headquartered in Davidson, North Carolina. It employs approximately 21,000 people and operates through Industrial Technologies and Services, or ITS, and Precision and Science Technologies, or P&ST.
ITS sells compressors, air treatment equipment, vacuum and blower systems, fluid transfer equipment, loading systems, power tools, lifting equipment, controls, parts, consumables, and services. P&ST sells pumps, gas boosters, hydrogen compression systems, liquid handling equipment, dosing systems, laboratory technologies, and medical and life-science components.
▌Common Questions
Frequently asked questions
+Is IR stock a buy right now?
IR is a Hold, not a Buy, because the business quality is strong but the valuation already reflects much of the improvement. Q2 showed $2.05B of revenue, $0.86 of adjusted EPS, and solid order momentum, yet leverage and a premium multiple keep the risk-reward balanced.
+What is IR's fair value?
IR's fair value is $82. We arrive at that view using the report's 18.9x forward earnings multiple, 2026 adjusted EPS guidance of $3.45 to $3.57, and the company’s improving mix from a 36% aftermarket base and 31.5% P&ST margins, while still discounting for $4.85B of debt.
+
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
The company sells through direct representatives, distributors, and OEM channels. Its brand portfolio includes Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, ARO, Dosatron, Haskel, Milton Roy, Seepex, Thomas, Welch, and other specialized names. The breadth matters because customers often buy systems rather than isolated components.
IR generated $7.65B of revenue in 2025. ITS contributed $6.06B, or 79.2% of total revenue, while P&ST contributed $1.59B, or 20.8%. P&ST has expanded from 18.1% of revenue in 2023 to 20.8% in 2025, giving the company a gradually more balanced portfolio.
Business Segment Deep Dive
ITS remains the financial anchor. Q2 2026 revenue reached $1.62B, up 9% year over year and 4% organically. Segment adjusted EBITDA was $435M, producing a 26.8% margin. Organic revenue growth was positive in every region, and global compressor orders increased by low single digits.
The segment has a useful combination of short-cycle and long-cycle demand. North American compressor orders increased at a high-single-digit rate, while delayed blower and vacuum projects in Europe and the Middle East affected the order pattern. Management described those projects as delayed rather than canceled, and July produced low-double-digit to mid-teens organic order growth.
P&ST is smaller but faster growing and more profitable. Q2 revenue was $427M, up 8% year over year and 4% organically. Orders increased 11% reported and 7% organically. Adjusted EBITDA rose 15% to $135M, while the adjusted EBITDA margin expanded 200 basis points to 31.5%.
Life Sciences delivered low-double-digit organic order growth, supported by biopharma and GLP-1-related activity. Precision Technologies grew at a mid-single-digit organic rate. The segment's improving mix and margin expansion provide a credible path for IR to raise the quality of its consolidated earnings over time.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
The flagship product family is IR's compressed-air and flow-creation platform. Compressors, vacuum systems, blowers, air treatment equipment, nitrogen generation, controls, and service products address processes where a failure can interrupt production. Management said compressors can represent approximately 30% of industrial electricity consumption in a manufacturing facility, which gives customers a direct economic reason to replace inefficient equipment.
In Q2, IR highlighted a plug-and-play nitrogen generation solution combining OxyWise, Gardner Denver, and York technologies. The factory-tested system is designed to simplify commissioning, speed deployment, and provide life-cycle support. This is a good example of IR moving beyond a single machine toward an integrated solution with more opportunities for service and cross-selling.
P&ST's Dosatron installation-ready dosing systems offer a second flagship opportunity. The standardized systems are designed to reduce installation complexity and improve reliability in water, agriculture, food, and industrial applications. Q2 P&ST revenue growth and a 31.5% adjusted EBITDA margin show that specialized flow-control products can carry stronger economics than basic equipment.
Innovation & Competitive Advantage
IR's competitive advantage is commercial and operational rather than dependent on a single patent. The company combines more than 90 brands, a broad product range, application engineering, global distribution, and an installed base that supports parts and service sales. Aftermarket revenue represented 36% of Q2 revenue, making the business less dependent on new equipment orders alone.
The IRX operating system is another important differentiator. Management linked IRX to productivity, execution, and the 200-basis-point margin expansion in P&ST. The framework is most valuable when it converts a collection of acquired businesses into a more consistent commercial and operating platform.
M&A remains central to the strategy. IR closed the acquisition of Lone Star Blowers, which is expected to add approximately $50M of annual revenue, and signed Fai Filtri, expected to add approximately $30M of annual revenue after closing. Both transactions expand filtration, blower, service, and aftermarket capabilities. The company also reported 11 additional transactions under letters of intent.
Operations & Supply Chain
Q2 orders exceeded $2.0B, up 5% year over year, with organic order growth of 2%. Book-to-bill was 1.0x. Short- and medium-cycle orders increased at a mid-single-digit rate, while the timing of several large projects held back the quarterly order comparison.
Management reported that the delayed long-cycle projects began to return in July. The longer projects generally run for six to 18 months, so the order recovery is more important for 2027 backlog than for immediate revenue. That pattern gives IR a useful forward demand signal without eliminating the timing risk inherent in project businesses.
The main operational pressure is pricing in China. ITS margin fell to 26.8% because inflation was harder to offset with price in China, while IR also invested in new technology and commercial applications. Management expects first-half pricing actions, productivity projects, and lower incentive costs to support a second-half margin ramp.
Aftermarket revenue at 36% of Q2 sales provides a buffer against equipment volatility. The business also generated $269M of quarterly free cash flow, up approximately 28% year over year. That cash generation gives IR flexibility to fund acquisitions, dividends, buybacks, and debt reduction, although capital allocation must remain disciplined because total debt is substantial.
Market Analysis
IR operates across industrial machinery, compressed air, vacuum, pumps, fluid handling, life sciences, water, food and beverage, electronics, energy, and clean technology. External market estimates place the broad industrial machinery market at approximately $0.87T in 2026, rising to $1.38T by 2032. Factory automation is estimated at $275B in 2025 and $435B in 2030.
The strongest structural demand drivers are energy efficiency, factory modernization, automation, connected equipment, and aftermarket service. IR's products fit these trends because customers can reduce electricity consumption, improve uptime, automate dosing and fluid movement, and monitor equipment across its life cycle.
The market is not uniformly strong. Industrial equipment demand depends on customer capital spending, access to financing, project timing, and regional economic conditions. Q2 provided a favorable data point through positive organic revenue growth in every region, but the delayed European and Middle Eastern projects show how quickly timing can distort reported orders.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
IR serves manufacturers, process industries, OEMs, distributors, laboratories, medical customers, food and beverage companies, water and wastewater operators, chemical processors, and clean-energy developers. The customer base is broad, which reduces dependence on any single end market.
The geographic mix is similarly diversified. The Americas represent approximately 50% of revenue, EMEA about one-third, and Asia Pacific about 15%, with China around 10% of total revenue. Q2 Americas ITS orders rose at a high-single-digit rate, China organic revenue grew at a low-double-digit rate, and EMEA weakness was concentrated in project timing.
Customers often purchase based on total cost of ownership rather than initial equipment price. Reliability, energy use, service availability, replacement parts, and application support can matter more than the lowest bid. That dynamic supports IR's aftermarket revenue and creates switching costs once equipment is installed and integrated into a production process.
Competitive Landscape
The competitive field includes Atlas Copco, Kaeser, Busch, Pfeiffer Vacuum, Sullair, Quincy Compressor, and regional specialists. Competition varies by product family. Atlas Copco, Busch, and Pfeiffer are prominent in compressed air and vacuum, while pumps, fluid handling, tools, and lifting equipment have more fragmented rival groups.
IR's advantage is breadth. Its portfolio spans compressors, vacuum systems, blowers, pumps, fluid transfer, dosing, power tools, lifting, controls, and services. More than 90 brands give the company multiple entry points into customer accounts, while the installed base supports recurring parts and service demand.
The weakness is that breadth does not guarantee pricing power in every market. Management specifically identified China as the most challenging region for pricing, and ITS margin declined 180 basis points in Q2. The competitive moat is strongest in mission-critical applications and aftermarket support, and weaker where equipment is more standardized.
Macro & Geopolitical Landscape
IR's 2026 filing discussions identified inflation, elevated interest rates, political and regulatory uncertainty, potential trade-policy changes, tariffs, and geopolitical instability as business risks. These factors can affect customer capital budgets, project approvals, freight costs, manufacturing expenses, and currency translation.
China remains the clearest pressure point. Q2 China organic revenue grew at a low-double-digit rate, but management said pricing remains difficult because original equipment carries lower margins than aftermarket products. That is a mixed signal: volume is healthy, but translating volume into profit requires better mix and future service revenue.
Energy efficiency is a favorable macro lever. Management said compressors can account for approximately 30% of industrial electricity consumption in a manufacturing facility. Higher power prices can shorten the payback period for replacing older equipment, supporting demand even when customers remain cautious about broader capital projects.
IR also expects potential IEEPA tariff refunds in the second half of 2026, although those benefits are excluded from adjusted EBITDA and adjusted EPS guidance. The company reached an initial $187.5M recovery agreement tied to an insurance claim related to the ILC Dover transaction and collected $25M in Q2.
Balance Sheet Health
▌Premium Members Only
$4.85B of debt versus $1.25B of cash leaves Ingersoll Rand with leverage that is manageable but still a key constraint on upside.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Ingersoll Rand combines an established industrial franchise with a faster-growing precision technology platform. Q2 2026 confirmed that the model can produce positive organic growth across regions, strong P&ST margins, healthy free cash flow, and renewed order momentum. The aftermarket base and IRX operating system add durability that many equipment manufacturers lack.
The investment case is not risk-free. Debt is meaningful, China pricing remains difficult, ITS margins contracted in Q2, and 2025 net income declined despite higher revenue and operating income. The stock therefore needs continued execution rather than a heroic narrative.
At approximately $78.57, IR is close to the report's $82 fair-value estimate. That supports a Hold rating for a moderate-risk investor. A pullback toward $67 would improve the entry point materially, while prices near $98 or above would require stronger earnings delivery than the current data justify.
Why does Ingersoll Rand get a Hold rating?
Ingersoll Rand gets a Hold because the company is executing well, but the stock is not cheap enough to justify a more aggressive stance. Revenue growth, free cash flow conversion near 95%, and raised guidance are positives, but 31.1x trailing earnings and leverage limit the margin of safety.
+What are the biggest positives for IR stock?
The biggest positives are the mission-critical equipment franchise, a 36% aftermarket mix, and improving profitability in Precision and Science Technologies. Q2 organic revenue growth was 4%, orders were just over $2.0B, and management said adjusted EPS should land near the high end of guidance.
+What is the main risk for Ingersoll Rand investors?
The main risk is that the stock already trades at a premium while carrying meaningful debt. IR has $4.85B of debt against $1.25B of cash, and the report says the current price leaves the risk-reward balanced rather than one-sided.
▌For Active Investors
Want Reports Like This on Any Stock?
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.